Antibodies to a nonconjugated prion protein peptide 95-123 interfere with PrPSc propagation in prion-infected cells

Cellular and Molecular Neurobiology

Volumn 27, Issue 3, 2007, Pages 271-284

  Oboznaya, Maria B ^a   Gilch, Sabine ^b   Titova, Maia A ^a   Koroev, Dmitry O ^a   Volkova, Tatyana D ^a   Volpina, Olga M ^a   Schätzl, Hermann M ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti peptide antibodies; Nonconjugated peptide; Prion peptide; Prion protein

Indexed keywords

FREUND ADJUVANT; ISOPROTEIN; PRION PROTEIN; PRION PROTEIN[161-191]; PRION PROTEIN[175-191]; PRION PROTEIN[203-229]; PRION PROTEIN[213-229]; PRION PROTEIN[95-123]; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CONJUGATION; CONTROLLED STUDY; COW; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; MOUSE; NONHUMAN; PATHOGENICITY; PRION DISEASE; PRIORITY JOURNAL; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PRION DISEASES; PROTEIN BINDING; PRPSC PROTEINS; RABBITS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TITRIMETRY; TUMOR CELLS, CULTURED; VACCINATION;

BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 34247214020     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-006-9108-y     Document Type: Article

References (28)

1. Aguzzi, A., and Polymenidou, M. (2004). Mammalian prion biology: One century of evolving concepts. Cell 116:1-15.
2. Brennan, F. R., and Dougan, G. (2005). Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies. Vaccine 23:3210-3222.
3. Enari, M., Flechsig, E., and Weissmann, C. (2001). Scrapie prion protein accumulation by scrapie infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98:9295-9299.
4. Ertmer, A., Gilch, S., Yun, S. W., Flechsig, E., Klebl, B., Stein-Gerlach, M., Klein, M. A., and Schatzl, H. M. (2004). The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prioninfected cells. J. Biol. Chem. 279:41918-41927.
5. Feraudet, C., Morel, N., Simon, S., Volland, H., Frobert, Y., Creminon, C., Vilette, D., Lehmann, S., and Grassi, J. (2005). Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. 280:11247-11258.
6. Fernandez-Escamilla, A.-M., Rousseau, F., Schymkowitz, J., and Serrano, L. (2004). Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotech. 22:1302-1306.
7. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., and Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature 362(6420):543-546.
8. Gilch, S., Winklhofer, K. F., Groschup, M. H., Nunziante, M., Lucassen, R., Spielhaupter, C., Muranyi, W., Riesner, D., Tatzelt, J., and Schatzl, H. M. (2001). Intracellular re-routing of prion protein prevents propagation of PrPSc and delays onset of prion disease. EMBO J. 20:3957-3966.
9. Gilch, S., Wopfner, F., Renner-Muller, I., Kremmer, E., Bauer, C., Wolf, E., Brem, G., Groschup, M. H., and Schatzl, H. M. (2003). Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion infected cells. J. Biol. Chem. 278:18524- 18531.
10. Kretzschmar, H. A., Prusiner, S. B., Stowring, L. E., and DeArmond, S. J. (1986). Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122:1-5.
11. Long, J. R., Tang, L. M., Qiu, X. P., Zeng, F. T., Xie, X. H., and Zhang, Y. P. (2004). Sequence variation in the rabbit major histocompatibility complex DQA gene. Proceedings of the 8th World Rabbit Congress, Puebla, Mexico: 96-101.
12. Magri, G., Clerici, M., Dall'Ara, P., Biasin, M., Caramelli, M., Casalone, C., Giannino, M. L., Longhi, R., Piacentini, L., Della Bella, S., Gazzuola, P., Martino, P. A., Della Bella, S., Pollera, C., Puricelli, M., Servida, F., Crescio, I., Boasso, A., Ponti, W., and Poli, G. (2005). Decrease in pathology and progression of scrapie after immunization with synthetic prion protein peptides in hamsters. Vaccine 23:2862-2868.
13. Nunziante, M., Gilch, S., and Schatzl, H. M. (2003). Prion diseases: From molecular biology to intervention strategies. Chem. Bio. Chem. 4:1268-1284.
14. Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., Dwek, R. A., Burton, D. R., and Prusiner, S. B. (2001). Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412:739-743.
15. Perrier, V., Solassol, J., Crozet, C., Frobert, Y., Mourton-Gilles, C., Grassi, J., and Lehmann, S. (2004). Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPc degradation. J. Neurochem. 89:454-463.
16. Polymenidou, M., Heppner, F. L., Pellicioli, E. C., Urich, E., Miele, G., Braun, N., Wopfner, F., Schatzl, H. M., Becher, B., and Aguzzi, A. (2004). Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl. Acad. Sci. USA 101:14670-14676.
17. Proske, D., Gilch, S., Wopfner, F., Schatzl, H. M., Winnacker, E. L., and Famulok, M. (2002). Prion-Protein-Specific Aptamer Reduces PrPSc Formation. Chem. Bio. Chem. 3:717-725.
18. Prusiner, S. B. (1997). Prion diseases and the BSE crisis. Science 278:245-251.
19. Rymer, D. L., Good, T. A. (2000). The role of prion peptide structure and aggregation in toxicity and membrane binding. J. Neurochem. 75(6):2536-2545.
20. Schwarz, A., Kratke, O., Burwinkel, M., Riemer, C., Schultz, J., Henkleinb, P., Bammea, T., and Baier, M. (2003). Immunization with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci. Lett. 350:187-189.
21. Sette, A., and Fikes, J. (2003). Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 15:461-470.
22. Sigurdsson, E. M., Brown, D. R., Daniels, M., Kascsak, R. J., Kascsak, R., Carp, R., Meeker, H. C., Frangione, B., and Wisniewski, T. (2002). Immunization delays the onset of prion disease in mice. Am. J. Pathol. 161:13-17.
23. Souan, L., Tal, Y., Felling, Y., Cohen, I. R., Taraboulos, A., and Mor, F. (2001). Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur. J. Immunol. 31:2338-2346.
24. Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R., Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., and Forloni, G. (1993). Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. 90(20):9678-9682.
25. Tal, Y., Souan, L., Cohen, I. R., Meiner, Z., Taraboulos, A., and Mor, F. (2003). Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice. J. Neurosci. Res. 71:286-290.
26. Udenfriend, S., and Meienhoferm, J. (1987). The peptides: Analysis, synthesis and biology, vol. 9, Academic Press, London.
27. White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J., and Hawke, S. (2003). Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422:80-83.
28. Ziegler, J., Viehrig, C., Geimer, S., Rosch, P., and Schwarzinger, S. (2006). Putative aggregation initiation sites in prion protein. FEBS Lett. 580(8):2033-2040.